English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

Simcere Partners with Suzhou NeuPharma on Cancer Drug

Oct. 9, 2011

On October 10, Simcere Pharma signed a strategic cooperation agreement with Suzhou NeuPharma to develop and produce novel drugs. The first candidate is a cancer drug, which is expected to be ready to apply for clinical research approval from both the Chinese SFDA and the US FDA in 2013. Simcere will contribute its production and marketing expertise, while NeuPharma will be responsible for developing the drug candidates.